Particle.news
Download on the App Store

Jacobs Beats in Q4 and Raises FY26 Outlook as Backlog Hits Record

Investors sold the stock on concern over a GAAP profit drop tied to prior mark-to-market effects.

Overview

  • Adjusted EPS for Q4 came in at $1.75 versus the $1.68 estimate, with revenue at about $3.2 billion, up 6.6% year over year and ahead of forecasts.
  • Fiscal 2026 guidance calls for adjusted EPS of $6.90 to $7.30, alongside projected adjusted net revenue of $9.217–$9.564 billion, an adjusted EBITDA margin of 14.4%–14.7%, and a free cash flow margin of 7%–8%.
  • Total backlog reached a record $23.1 billion, up 5.6% from a year ago, with a book-to-bill ratio of 1.1x indicating sustained demand.
  • GAAP EPS fell 55.9% to $1.05 as prior-year mark-to-market gains related to a former Amentum stake rolled off, while adjusted EBITDA rose 12% to $324 million and adjusted net revenue increased 5.8% to $2.2 billion.
  • Management returned a record $1.1 billion to shareholders in fiscal 2025 and disclosed an Owner’s Representative role for PsiQuantum’s planned quantum computing facility in Chicago.